Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK, Zantac
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.
STAT
5d
The company also agreed to pay $70 million to settle a whistleblower lawsuit
GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac ...
4d
FTSE 100 Live 10 October: GSK shares rise on $2.2bn Zantac settlement, property firm gets £1.1bn bid
GSK’s $2.2 billion Zantac settlement today put its shares top of the FTSE 100, albeit still well short of their level before ...
4d
on MSN
UK borrowing costs hit three-month high amid ‘buyers’ strike’ fears; GSK’s shares surge after $2.2bn Zantac settlement – business live
Yield on 10-year UK government debt hits highest since early July, while inflation has eased in the US. 15:39 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
GOP ad mistake in MI
BP endorses Trump
MA town fines resident
Rare comet spotted
Detroit off-duty officer killed
Signals caution on rate cuts
Files for bankruptcy
Rapper Ka dies at 52
AR casino challenge ruling
2,471-pound pumpkin wins
Arrests at the NYSE
Sued by workers for injuries
NJ Transit train hits tree
Dow, S&P 500 hit records
Tech founder's murder trial
Urged to reverse trans ban
Indigenous Peoples Day
On their way to DC
BCBS settles antitrust claims
EU trial about funds
COVID linked to diabetes?
Approves mpox vaccine
Game Freak data breach
FEMA pauses aid in NC
Harbaugh’s heart scare
FL power to be restored
Human smell study
Rally suspect denies plot
Hit with new civil lawsuits
Ethel Kennedy’s funeral
Medicare open enrollment
Related topics
GSK
GlaxoSmithKline
Ranitidine
United States
Feedback